期刊文献+

lncRNA CoroMarker在冠心病患者中的表达差异及意义 被引量:1

Expression Difference and Significance of LncRNA CoroMarker in Patients with Coronary Heart Disease
在线阅读 下载PDF
导出
摘要 目的探讨lncRNA CoroMarker、lncRNA IFNG-AS1、lncRNA AF131217.1在冠状动脉粥样硬化性心脏病(coronary atherosclerotic heart disease,CAD)患者中的表达差异及临床意义。方法入选新疆医科大学附属中医医院2019年3月~2020年9月CAD患者40例为病例组,冠状动脉正常者40例为对照组,通过qRT-PCR法检测外周血单核细胞中lncRNA CoroMarker、lncRNA AF131217.1和lncRNA IFNG-AS1表达水平,ELISA法测定外周血IL-6、TNF-α水平。采用ROC曲线分析3种lncRNA对CAD患者的诊断价值及与IL-6、TNF-α水平的相关性。结果病例组lncRNA IFNG-AS1、lncRNA AF131217.1表达水平与对照组比较,差异无统计学意义(P>0.05),lncRNA CoroMarker表达水平显著升高(P<0.05),IL-6、TNF-α水平显著升高(P<0.05)。ROC曲线分析结果显示lncRNA IFNG-AS1、lncRNA AF131217.1和lncRNA CoroMarker的AUC分别为0.360(95%CI:0.180~0.540,P=0.13)、0.445(95%CI:0.259~0.631,P=0.55)、0.960(95%CI:0.908~1.000,P=0.00)。在相关性分析中,lncRNA CoroMarker与IL-6、TNF-α呈线性正相关,r值分别为0.437(P=0.005)、0.740(P=0.000)。结论lncRNA Coro-Marker在CAD患者血清单核细胞中表达水平明显高于对照组,lncRNA CoroMarker可能作为一种潜在的诊断冠心病的血清标志物,且可能与IL-6、TNF-α等炎性因子的表达呈正相关。 Objective To investigate the effect and clinical significance of lncRNA CoroMarke,lncRNA IFNG-AS1 and lncRNA AF131217.1 in patients with coronary atherosclerotic heart disease.Methods Forty patients with coronary atherosclerotic heart disease was recruited from the Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital afliated of the Xinjiang Medical Universi-ty from March 2019 to September 2020.Forty patients with normal coronary angiography served as a normal control group.The relative ln-cRNA CoroMarker,lncRNA AF131217.1 and lncRNA IFNG-AS1 expression level in monocytes derived from peripheral blood was de-tected by qRT-PCR.The levels of pro-inflammatory cytokines TNF-αand IL-6 were measured by ELISA.The receiver operating characteristic(ROC)curve was used to evaluate the diagnostic value of differentially expressed lncRNA for patients with coronary artery disease(CAD).Results No significant difference in expression level of lncRNA IFNG-AS1 and lncRNA AF131217.1 was observed between the two groups(P>0.05).Compared with the normal control group,the expression level of lncRNA CoroMarker and the level of TNF-αand IL-6 were increased in patients with CAD.ROC analyses showed that lncRNA IFNG-AS1(AUC=0.360;95%CI:0.180-0.540),lncRNA AF131217.1(AUC=0.445;95%CI:0.259-0.631)and lncRNA CoroMarker(AUC=0.960;95%CI:0.908-1.000)were predictive of for patients with CAD(P<0.05).IL-6(r=0.437,P=0.005)and TNF-α(r=0.740,P<0.001)correlated positively with lncRNA CoroMarker.Conclusion Compared with the normal control group,lncRNA CoroMarker ex-pression level in monocytes derived from peripheral blood was increased in patients with CAD.lncRNA CoroMarkermay serves as a poten-tial diagnostic biomarker in patients with CAD.And it may be positively correlated with the level of IL-6,TNF-αand other inflammato-ry factors.
作者 杨毅 张莉晶 孙龙飞 姜海兵 YANG Yi;ZHANG Lijing;SUN Longfei(Department of Cardiology,Chinese Medicine Hospital Affiliated to Xinjiang Medical University,Xinjiang 830000,China)
出处 《医学研究杂志》 2022年第1期93-97,共5页 Journal of Medical Research
基金 省部共建中亚高发病成因与防治国家重点实验室项目(SKL-HIDCA-2019-ZY8)。
关键词 冠状动脉粥样硬化性心脏病 长链非编码RNA 诊断意义 Coronary atherosclerotic heart disease Long non coding RNA coroMarker Diagnostic significance
  • 相关文献

参考文献8

二级参考文献112

  • 1Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 2Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 3Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 4Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 5O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 6Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 7Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
  • 8Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.
  • 9Kjekshus JK, Maroko PB, Sobel BE. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res,1972,6(5) :490-499.
  • 10Kleber AG. ST-segment elevation in the electrocardiogram: a sign of myecaniial iechemia. Cardiovasc Res, 2000,45(1) :111-118.

共引文献2388

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部